4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Osteoarthritis in 1 studies
4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor
Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SW | 1 |
| Rho, JH | 1 |
| Lee, SY | 1 |
| Yoo, SH | 1 |
| Kim, HY | 1 |
| Chung, WT | 1 |
| Yoo, YH | 1 |
1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Osteoarthritis
| Article | Year |
|---|---|
Alpha B-Crystallin Protects Rat Articular Chondrocytes against Casein Kinase II Inhibition-Induced Apoptosis.
Topics: alpha-Crystallin B Chain; Animals; Apigenin; Apoptosis; Benzimidazoles; Cartilage, Articular; Casein | 2016 |